Cynon Taf Community Housing Group Bolsters Executive Team with Three Key Appointments
The appointments come as the Group moves forward with delivering its new strategic plan for 2025 – 2029 with a mission to provide quality homes for current and future generations and be an inspiring, trusted community partner and employer.
Angharad Rogers, currently Head of Housing at CTCHG, will move into the role of Director of Housing and Communities, with responsibility for subsidiary Down to Zero in her portfolio. Angharad has worked at CTCHG for almost 20 years and will use her insights and knowledge of the Group's tenants and communities to maximise its impact locally.
Emma Brute will take up the new role of Director of Organisational Development and Business Improvement.
A housing professional by background, Emma is currently Head of Information and Business Transformation at United Welsh. She brings expertise in leading customer-focussed transformation resulting in increased customer satisfaction, streamlined operations and enhanced compliance.
Emma also brings governance experience as a Board member of Cyfannol Women's Aid and, previously, of Monmouthshire Housing Association.
Owain Roberts, recently Director of Property and Place at Newport City Homes, will take up the new role of Director of Assets, Decarbonisation and Growth. He will be responsible for the Assets and Development teams and will take on the technical oversight of the Group's decarbonisation work and Welsh Housing Quality Standard.
Owain brings significant industry experience in property maintenance, development, repairs, building safety, asset management and decarbonisation and in driving service improvements. He also has previous governance experience as a member of the Board of Blaenau Gwent Care & Repair.
All three Directors will join Group Director of Finance, Alison Williams to form the Group's Executive Team, reporting directly to Auriol Miller, Group CEO.
Auriol Miller, CTCHG CEO, said:
'Following a rigorous recruitment process, I am really pleased to be welcoming Angharad, Emma and Owain to the Executive Team at Cynon Taf Community Housing Group.
'Each brings with them significant experience in their respective fields, and I am looking forward to working with them to deliver against year one of our new strategic plan and shared vision for healthy valleys communities where everyone feels connected, supported and hopeful about the future.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
2 days ago
- Daily Mirror
Warning to anyone using AI for money advice and why it could be costing you more
MoneyMagpie Editor and financial expert Vicky Parry warns about the ways AI can cost you money – and how to avoid it Artificial intelligence (AI) seems to be everywhere these days. But did you know that it could be costing you more money each month than you need to spend? Follow these tips to avoid the AI and keep on top of your finances. When AI can be useful We're not here to bash AI: it does have useful applications. For example, apps like Emma help you analyse your spending across different bank accounts and can help you identify expenses you've forgotten about, like unused subscriptions. AI can also be handy for those dipping their toe into their investing journey. Robo advisors and AI investment programmes can help you learn more about investing and 'set and forget' investing small amounts to try out the stock market. However, there are also lots of ways AI is actually costing you more cash each month – here's what to look out for and how to avoid these sneaky expenses. Cancel your software upgrade Many subscription-based softwares now include AI tools – and they're making you pay for the privilege. For example, Microsoft rolled out CoPilot and then raised the price of Microsoft 365 to account for the 'added benefit' of AI. Where possible, keep control of your spending by rejecting the AI tools. Many software companies will offer a rollback or a 'basic' option without the 'premium' AI tools – you may have to contact their helpdesk to get it, though. Or, with Microsoft Office, consider either buying a single Home Office licence which is offline, single-payment, and not subscription (and without AI), or switching to free options like Google Docs or Libre Office. Don't sign away your ownership Check the terms and conditions of software, too. Companies are sneaking in terms that allow them to use your work to train their AI models, or use your privately saved or transferred content via the software to 'use in perpetuity' how they wish. This could mean using your photos for advertising, marketing, or even demographic training to target adverts more precisely. WeTransfer recently had to walk back such a change. The file transfer service is often used by creatives to send large-sized files to each other, and the change in terms suggested this content could be used by WeTransfer with impunity. This caused outrage in users, as it held huge potential to devalue their creative work. Since the outcry, WeTransfer has altered the wording and confirmed user content will not be used to train their AI. While most companies insist that this kind of wording is designed to improve the in-house customer experience, the terms can be vague. This means you might be granting access to your content – including stuff that would normally be considered under your copyright, like images and writing – for companies to use as they wish. If that turned into using it for advertising, or putting your personal images on marketing content for the world to see, you could lose revenue from your business or even suffer reputational damage. Always read the fine print – no matter how boring it might be! It could save you from financial loss. Built-in device AI Laptops, tablets, and smartphones all already use AI in some forms. However, new devices are now using it as a selling point, with advanced features connecting a wide range of features to make things easier for you. For example, you could more easily edit your photos at the click of a button – or a calendar invite can be set to give you an audible reminder on your Amazon Echo. However, you're paying for this software and might not even use it. More than that, the design of the newest AI connecting everything, everywhere makes a lot of people uncomfortable and can cause extra anxiety. Look for second-hand older models without the built-in AI, or some 'dumb' tech which operates 'old school' ways, like the Chatsie phone with its text interface. Some budget smartphones will also not have the super-duper AI tools included, too. Turn off personalised advert options A more insidious form of AI that makes you spend money is the way many platforms allow tracking cookies for personalised adverts. This is not new, it's been around for a long time – but AI has made it even easier than before for marketers to finesse their target audience and make sure you're served adverts for things you're more likely to be interested in. Have you ever noticed that you paused a little too long on an advert for something while you're scrolling, and then suddenly your feed is filled with similar products? It's how retailers get you! Turning off personalised adverts means you'll be served all kinds, rather than only the things you want or are interested in buying. This will reduce the impulsivity of online shopping, especially when you're scrolling social media. Go old school for research ChatGPT not only uses ten times more energy to reply to a query than a Google search, but it also hallucinates. That's the term for when it makes up answers – basically, it makes assumptions based on patterns rather than uses critical thinking like humans can. Why can this cost you money? It could cost you your job! If you're regularly using ChatGPT for research, you might think it's saving you time – but with a high error rate, not fact-checking the information provided to you could mean huge, and costly, mistakes. The popular AI tool even states below the query bar that it isn't accurate and should be checked. So, why waste time asking ChatGPT in the first place? 'Old-fashioned' Google searches will help you find the best resources, double-check details, and save you time on fact-checking the AI results in the first place. Remember that the AI summary that comes up on a Google search can also hallucinate (a classic example is it not recognising that 2015 was ten years ago), so keep scrolling to reach the web pages instead. You can avoid any AI summaries by using -ai at the end of your search query. Some of the brands and websites we mention may be, or may have been, a partner of However, we only ever mention brands we believe in and trust, so it never influences who we prioritise and link to.
North Wales Live
5 days ago
- North Wales Live
Llandudno brewery with taproom plans further expansion after securing loan
One of North Wales' leading craft breweries has set its sights on further expansion and business growth after securing a £150k loan. Llandudno 's Wild Horse Brewing Co, which was established in 2015, secured a finance package from BCRS Business Loans, following an introduction by Bathgate Business Finance. The deal has assisted the company's future growth plans, whilst also supporting renovation work and renewable energy solutions. Wild Horse Brewing Co – on Cae Bach, Builder Street – has focused on a period of investment, expanding to purchase a permanent tap room whilst also installing solar panels. And with the tap room now attracting a growing customer base, whilst providing a venue for trade customers to sample the range of beers in the space in which they're brewed, the brewery sought to consolidate finance to move the business forward. Emma Faragher, who set up Wild Horse Brewing Co with husband Dave, said: 'Last year we sold 444,000 pints of our beer, and the majority of sales come directly from pubs, but there were opportunities we wanted to take advantage of to further expand the business. 'We had run a pop-up taproom on and off for a couple of years, but with the brewing space expanding to cope with sales demand, we were short of space to continue in the same fashion. Join the North Wales Live Whatsapp community now 'The tenant next door had been operating for over 40 years, so when the space came up for sale, we knew it was the right direction for our business and we needed to act fast.' Wild Horse Brewing Co were put in contact with Bathgate Business Finance, which then introduced Emma and Dave to BCRS Business Loans' business development manager, James Pittendreigh. Working together, the brewery was supported with a £150,000 finance package from BCRS Business Loans, via the British Business Bank's £130m Investment Fund for Wales and Community Investment Enterprise Fund (CIEF). Emma added: 'At previous junctions of the business, we had used our capital to allow us to purchase the site next door, in a timely fashion we looked at other opportunities. After securing the taproom, we knew that there were opportunities to consolidate the finance we had in place, and BCRS was fantastic and took the time to get to know the business and the journey we were on. 'Through the £30,000 funding from the Investment Fund for Wales, we've been able to carry out work to the car park area which has created more outdoor space for customers. 'This funding has been fantastic; without it we wouldn't have the same growth opportunities. 'The tap room is currently open Thursday to Sunday with ten rotating beers, and we're looking forward to attracting more customers through the doors, both trade and individual.' BCRS Business Loans' James Pittendreigh said: 'Emma, Dave, and the team at Wild Horse Brewing Co have come a long way in a relatively short period, and we're delighted to support them as they continue on their growth path. 'In supporting companies across Wales, we seek to work in partnership with our wider network, and this deal saw Williams Denton refer their customer to Bathgate, who in turn pointed Emma and Dave in the direction of BCRS.'
Times
6 days ago
- Times
GSK profits lifted by strong cancer drug sales
Strong sales of specialty medicines during the first half of the year has led GSK to expect group revenue and profit growth towards the top end of its forecast range. The FTSE 100 company posted total second quarter sales of almost £8 billion, up 6 per cent at constant currencies and ahead of City forecasts of £7.8 billion. Specialty medicines rose 15 per cent to £3.3 billion, including cancer treatments up 42 per cent and HIV drug sales 12 per cent. Core operating profit rose 12 per cent to £2.6 billion in the quarter. • Business live: FTSE 100 drops on poor corporate results The performance led GSK to forecast revenue growth this year towards the top end of its previously-guided range of between 3 and 5 per cent. Similarly it expects core operating profit growth to be towards the top of its 6 to 8 per cent range. GSK said that its guidance reflected tariffs already enacted and the US-EU trade deal struck this week, adding that it was 'positioned to respond to the potential financial impact of tariffs, with mitigation options identified. Given the uncertain external environment, we will continue to monitor developments'. On Monday, President Trump reiterated threats to introduce tariffs on pharmaceutical imports soon as he seeks to pressure multinationals to increase manufacturing in the United States. Dame Emma Walmsley, GSK's group chief executive, said that the 'strong momentum in 2025 continues with another quarter of excellent performance driven mainly by specialty medicines, our largest business'. She added: 'We also continue to make very good progress in R&D, with three major FDA approvals achieved so far this year, 16 assets now in late-stage development, and four more promising medicines to treat cancer, liver disease and HIV expected to enter phase III and pivotal development by the end of the year.' A dividend of 16p per share was declared and GSK has spent £822 million on its £2 billion share buyback, which was announced at its full-year results earlier this year. Shares in GSK slid 8p, or 0.5 per cent, to £13.89 in early trading in London. Walmsley, 56, who has led GSK since 2017, said that the company remained confident in its its long-term outlook. GSK has set a target of generating group sales of more than £40 billion by 2031. However, there remains scepticism among some investors that it will hit that figure, with consensus forecasts instead of just £34 billion. It suffered a setback this month when the Food and Drug Administration, the regulator in America, the world's biggest drugs market, delayed a decision on approving Blenrep, a potential blockbuster blood cancer drug. The European Union, however, approved Blenrep for the treatment of adults with relapsed or refractory multiple myeloma. The UK has also given the green light. GSK, based in London's 'Knowledge Quarter', is one of Britain's two big pharma companies alongside AstraZeneca. It employs more than 65,000 people and operates in 75 markets. The group separated Haleon, its consumer healthcare business, as a standalone FTSE 100 company three years ago to focus on developing its core biopharma pipeline and to give it more firepower for bolt-on deals. On Monday it struck a $500 million deal with Hengrui Pharma, a Chinese pharmaceutical company, to develop up to a dozen new medicines as it deepens its partnerships in the country. GSK said on Wednesday that its agreement in May to pay up to $2 billion for a promising liver disease drug, the lead asset of Boston Pharmaceuticals, a US biopharma company, had been completed.
